Clinical Trials Logo

Hyperthyroidism clinical trials

View clinical trials related to Hyperthyroidism.

Filter by:

NCT ID: NCT03379181 Completed - Hyperthyroidism Clinical Trials

Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy

HEAT
Start date: July 18, 2017
Phase: Phase 4
Study type: Interventional

The overall objective of the HEAT study is to determine the acute effect of propranolol on energy expenditure in patients suffering from hyperthyroidism and to evaluate the consequences of the change of hyper- to euthyroidism on metabolism during the course of treatment, especially with regard to the reaction to cold ambient temperatures.

NCT ID: NCT03303053 Recruiting - Graves Disease Clinical Trials

Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism

ChoPS
Start date: May 11, 2017
Phase: Phase 3
Study type: Interventional

Hyperthyroidism is the second most common endocrine disorder in the world with Graves' disease being the commonest. Anti thyroid drugs including methimazole, carbimazole, and propylthiouracil are effective treatments but take in most cases between 6 to 8 weeks to achieve euthyroidism. This study aim to assess the efficacy of cholestyramine and prednisolone as adjunctive treatment to standard treatment in patients with overt hyperthyroidism in 4 weeks.

NCT ID: NCT03064542 Completed - Hyperthyroidism Clinical Trials

The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure

TRIBUTE
Start date: October 13, 2015
Phase:
Study type: Observational [Patient Registry]

To determine how thyroid status regulates the relationship between brown adipose tissue (BAT) volume/activity, white adipose tissue (WAT) partitioning and basal metabolic rate (BMR) in hyperthyroid patients transitioning to euthyroidism via antithyroid drugs. To compare euthyroid outcomes (BAT, WAT, BMR, body composition, body weight and insulin resistance) achieved by hypothalamus-pituitary-thyroid (HPT) set point vs. normal ranges of plasma free thyroxine 4 (FT4) and throxine stimulating hormone (TSH).

NCT ID: NCT02989103 Completed - All-Cause Mortality Clinical Trials

Hyperthyroid Follow-Up Study

Start date: December 6, 2016
Phase:
Study type: Observational

Background: Hyperthyroidism is a common disease. It is very common for women. It is usually treated with Radioiodine (I-131). Some people think that this might cause cancer, even many years later. Past studies of people with hyperthyroidism have not been clear about cancer risks after I-131. Researchers want to look at a group of people with the disease who got I-131 many years ago. They want to look at how their health was months and years later. Objective: To learn more about disease risks in relation to radiation from I-131 treatment for hyperthyroidism. Eligibility: People who were part of the previous study. These are people who were diagnosed with hyperthyroidism at U.S. and U.K. hospitals from 1946 to 1964. About 95% of the participants have already died. Design: Researchers will examine data already collected by the past study. This includes data on participants later cancers and other health outcomes after they had I-131 treatment. Researchers will compare that data to a National Death Index search. This was already done for data up through 2003. This study will cover 2004 2014. Researchers will not be in touch with study participants or their next of kin....

NCT ID: NCT02843542 Not yet recruiting - Clinical trials for Primary Hyperthyroidism

Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)

Start date: August 2016
Phase: N/A
Study type: Interventional

A comparative prospective study to evaluate different imaging modalities (pet-ct and pet-mr) prior to surgery in parathyroid tumor patients.

NCT ID: NCT02812888 Recruiting - Hyperthyroidism Clinical Trials

Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism

Start date: July 2016
Phase: N/A
Study type: Observational [Patient Registry]

Clustering of various metabolic parameters including abdominal obesity, hyperglycaemia, low high-density lipoprotein cholesterol, elevated triglycerides and hypertension have been used worldwide as metabolic syndrome to predict cardiometabolic risk. Thyroid dysfunction impacts on various levels of these components. Recent evidence from HepG2 cells indicates that betatrophin, also known as TD26/RIFL/lipasin/ANGPTL8/C19orf80, a secreted protein that regulates glucose, lipid metabolism, and energy homeostasis, is induced by T3. However, the role of betatrophin in hyperthyroid patients is unknown. The objective was to study serum betatrophin levels in hyperthyroid patients and the association of serum betatrophin levels with hyperthyroidism.

NCT ID: NCT02772705 Recruiting - Hyperthyroidism Clinical Trials

Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans

Start date: May 2016
Phase: N/A
Study type: Observational

The purpose of this study is to find out the capacity of standardized uptake value (SUV) using single-photo emission computed tomography and computed tomography (SPECT/CT) in diagnosing Grave's Disease (hyperthyroidism).

NCT ID: NCT02767245 Completed - Thyrotoxicosis Clinical Trials

Thiamine Supplement in Patients With Severe Hyperthyroidism

Start date: January 2014
Phase: N/A
Study type: Interventional

Thyrotoxicosis is a hypermetabolic state in which there is increased utilization of thiamine. Thiamine deficiency has been observed in association with hyperthyroidism. Several studies documented that thiamine treatment could improve signs and symptoms of congestive heart failure, or even improve left ventricular ejection fraction in patients without thyrotoxicosis. This pilot study aims to evaluate prevalence of thiamine deficiency and assess improvement of cardiovascular function after receiving thiamine supplement in thyrotoxic patients.

NCT ID: NCT02727738 Completed - Graves' Disease Clinical Trials

Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole

Start date: January 2014
Phase: N/A
Study type: Interventional

Evaluation of the efficacy of the combined treatment (methimazole plus selenium) in the control of hyperthyroidism as compared to methimazole alone in 30 Graves' disease (GD) untreated patients.

NCT ID: NCT02710799 Completed - Obesity Clinical Trials

Evaluation of the Effects of Teleconsultations on a Endocrinology Referral List

Start date: June 2015
Phase: N/A
Study type: Interventional

The aim of this study is evaluate the effects of telephone teleconsultations to primary care physicians (compared to the state's referral protocol) in the referrals waiting list for endocrinological appointments.